A Colorblind Constitution: What Abigail Fisher’s Affirmative Action Case Is Really About

When the NAACP began challenging Jim Crow laws across the South, it knew that, in the battle for public opinion, the particular plaintiffs mattered as much as the facts of the case. The group meticulously selected the people who would elicit both sympathy and outrage, who were pristine in form and character. And they had to be ready to step forward at the exact moment when both public sentiment and the legal system might be swayed.

Read more: A Colorblind Constitution: What Abigail Fisher’s Affirmative Action Case Is Really About

At Health Law Anniversary, Even Bigger Changes Loom

A roundtable of reporters weighs in on what’s changed since the ACA became law three years ago for consumers, businesses, state governments, and what's next for expanding Medicaid and launching exchanges.

Read more: At Health Law Anniversary, Even Bigger Changes Loom

In This Issue

As we implement the National HIV/AIDS Strategy and move forward toward our goal of achieving an AIDS-free generation, our biomedical toolbox becomes increasingly important. This week HIV specialist Dr. Teresa Mack tells us what we need to know about one of our most important new tools: treatment as prevention.

Read more: In This Issue

Treatment as Prevention: What You Need to Know

Every month, HIV specialist Theresa Mack, M.D., M.P.H.--an associate medical director at St. Luke's Medical Group in Harlem, N.Y.--will answer your most pressing HIV/AIDS questions.

For years we've known that with effective treatment, HIV becomes a chronic illness rather than a fatal one. However, there have been different schools of thought about when a person living with HIV/AIDS should begin treatment.

Read more: Treatment as Prevention: What You Need to Know